Dose–Effect Relationship of Alkylating Agents on Testicular Function in Male Survivors of Childhood Lymphoma

REFERENCES

• Brydøy M, Fossa S, Dahl O, Bjoro T. Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol. 2007;46:480–489.
   PubMed Web of Science ®Google Scholar
• Wasilewski-Masker K, Seidel KD, Leisenring W, et al. Male infertility in long-term survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study. J Cancer Surviv. 2014;8:437–447.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–2931.
   PubMed Web of Science ®Google Scholar
• Kenney LB, Cohen LE, Shnorhavorian M, et al. Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group. J Clin Oncol. 2012;30:3408–3416.
   PubMed Web of Science ®Google Scholar
• Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005;6:209–218.
   PubMed Web of Science ®Google Scholar
• Robison LL, Armstrong GT, Boice JD, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol. 2009;27:2308–2318.
   PubMed Web of Science ®Google Scholar
• Green DM, Liu W, Kutteh WH, et al. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. Lancet Oncol. 2014;15:1215–1223.
   PubMed Web of Science ®Google Scholar
• Rueffer U, Breuer K, Josting A, et al. Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol. 2001;12:1307–1311.
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM. Fertility after treatment for Hodgkin's disease. Ann Oncol. 2002;13(Suppl 1):138–147.
   PubMed Web of Science ®Google Scholar
• van Dorp W, van Beek RD, Laven JSE, et al. Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: a review. Hum Reprod Update. 2012;18:12–18.
   PubMed Web of Science ®Google Scholar
• Schrader M, Heicappell R, Müller M, Straub B, Miller K. Impact of chemotherapy on male fertility. Onkologie. 2001;24:326–330.
   PubMed Web of Science ®Google Scholar
• Lähteenmäki PM, Arola M, Suominen J, et al. Male reproductive health after childhood cancer. Acta Paediatr. 2008;97:935–942.
   PubMed Web of Science ®Google Scholar
• Kumanov P, Nandipati K, Tomova A, et al. Inhibin B is a better marker of spermatogenesis than other hormones in the evaluation of male factor infertility. Fertil Steril. 2006;86: 332–338.
   PubMed Web of Science ®Google Scholar
• Green DM, Zhu L, Zhang N, et al. Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort study. J Clin Oncol. 2013;31:1324–1328.
   PubMed Web of Science ®Google Scholar
• Donaldson SS, Link MP. Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol. 1987;5:742–749.
   PubMed Web of Science ®Google Scholar
• Bonadonna G, Santoro A. ABVD chemotherapy in the treatment of Hodgkin's disease. Cancer Treat Rev. 1982;9:21–35.
   PubMed Web of Science ®Google Scholar
• Weiner MA, Leventhal BG, Marcus R, et al. Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol. 1991;9:1591–1598.
   PubMed Web of Science ®Google Scholar
• Dörffel W, Lüders H, Rühl U, et al. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook. Klin Padiatr. 2003;215:139–145.
   PubMed Web of Science ®Google Scholar
• Nachman JB, Sposto R, Herzog P, et al., Children's Cancer Group. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol. 2002;20:3765–3771.
   PubMed Web of Science ®Google Scholar
• Patte C, Auperin A, Michon J, et al., Société Française d'Oncologie Pédiatrique. The Société Francaise d'Oncologie Peédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood. 2001;97:3370–3379.
   PubMed Web of Science ®Google Scholar
• Patte C, Kalifa C, Flamant F, et al. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol. 1992;20:105–113.
   PubMedGoogle Scholar
• Jabbour E, Koscienly S, Sebban C, et al. High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL). Leukemia. 2006;20:814–819.
   PubMed Web of Science ®Google Scholar
• Vannier JP, Patte C, Philip T, et al. Treatment of extensive B-cell lymphoma in children: studies of the French Pediatric Oncology Society. Bull Cancer. 1988;75:61–68.
   PubMed Web of Science ®Google Scholar
• Patte C, Michon J, Frappaz D, Leverger G. Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults. Baillieres Clin Haematol. 1994;7:339–348.
   PubMed Web of Science ®Google Scholar
• Cairo MS, Sposto R, Gerrard M, et al. Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study. J Clin Oncol. 2012;30:387–393.
   PubMed Web of Science ®Google Scholar
• Schellong G, Brämswig JH, Schwarze EW, Wannenmacher M. An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies. Bull Cancer. 1988;75:41–51.
   PubMed Web of Science ®Google Scholar
• Landman-Parker J, Pacquement H, Leblanc T, et al. Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90. J Clin Oncol. 2000;18:1500–1507.
   PubMed Web of Science ®Google Scholar
• Le Deley M, Rosolen A, Williams D, et al. Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: Results of the randomized ALCL99-Vinblastine trial. J Clin Oncol. 2010;28:3987–3993.
   PubMed Web of Science ®Google Scholar
• Brugieres L, Le Deley M, Pacquement H, et al. CD30 Anaplastic large-cell lymphoma in children: Analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood. 1998;92;3591–3598.
   PubMed Web of Science ®Google Scholar
• Viviani S, Santoro A, Ragni G, et al. Gonadal toxicity after combination chemotherapy for Hodgkin's disease: comparative results of MOPP and ABVD. Eur J Clin Oncol. 1985;21:601–606.
   PubMedGoogle Scholar
• van der Kaaij M, Heutte N, Le Stang N, et al. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d’Étude des Lymphomes de l'Adulte. J Clin Oncol. 2007;25:2825–2832.
   PubMed Web of Science ®Google Scholar
• Ben Arush MW, Solt I, Lightman A, et al. Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma. Pediatr Hematol Oncol. 2000;17:239–245.
   PubMed Web of Science ®Google Scholar
• Hobbie WL, Ginsberg JP, Ogle SK, et al. Fertility in males treated for Hodgkin's disease with COPP/ABVD hybrid. Pediatr Blood Cancer. 2005;44:193–196.
   PubMed Web of Science ®Google Scholar
• Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12–17.
   PubMedGoogle Scholar
• Dohle G. Male infertility in cancer patients: review of the literature. Int J Urol. 2010;17:327–331.
   PubMed Web of Science ®Google Scholar
• Green DM, Liu W, Kutteh WH, et al. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. Lancet Oncol. 2014;15:1215–1223.
   PubMed Web of Science ®Google Scholar
• van den Berg H, Furstner F, van den Bos C, Behrendt H. Decreasing the Number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. Pediatr Blood Cancer. 2004;42:210–215.
   PubMed Web of Science ®Google Scholar
• Mauz-Cörholz C, Hasenclever D, Dörffel W, et al. Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. J Clin Oncol. 2010;28:3680–3686.
   PubMed Web of Science ®Google Scholar
• van Casteren N, van der Linden G, Hakvoort-Cammel F, et al. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer. 2009;52:108–112.
   PubMed Web of Science ®Google Scholar
• Patte C, Auperin A, Gerrard M, et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007;109:2773–2780.
   PubMed Web of Science ®Google Scholar
• Landman-Parker J, Pacquement H, Leblanc T, et al. Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy—results of the French Society of Pediatric Oncology study MDH90. J Clin Oncol. 2000;18:1500–1507.
   PubMed Web of Science ®Google Scholar
• Jaffe N, Sullivan MP, Ried H, et al. Male reproductive function in long-term survivors of childhood cancer. Med Pediatr Oncol. 1988;16:241–247.
   PubMedGoogle Scholar
• Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metabol Clin North Am. 1998;27:927–943.
   PubMed Web of Science ®Google Scholar
• Sieniawski M, Reineke T, Josting A, et al. Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials. Ann Oncol. 2008;19:1795–1801.
   PubMed Web of Science ®Google Scholar